Replimune Group, Inc. — Director's Dealing 2020

Dec 17, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Replimune Group, Inc. (REPL)
CIK: 0001737953
Period of Report: 2020-12-14

Reporting Person: Franchi Jean M. (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-12-14	Common Stock	M	25000	$14.08	Acquired	25000	Direct
2020-12-14	Common Stock	S	17856	$43.70	Disposed	7144	Direct
2020-12-14	Common Stock	S	6755	$42.86	Disposed	389	Direct
2020-12-14	Common Stock	S	389	$42.09	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-12-14	Employee Stock Option (right to buy)	$14.08	M	25000	Disposed	2029-12-09	Common Stock (25000)	Direct

Footnotes

F1: The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on November 13, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended.

F2: The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.22 to $44.21. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

F3: The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.24 to $43.21. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

F4: The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.01 to $42.15. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

F5: The reporting person continues to hold options to acquire 211,350 shares of the Issuer's common stock, 20,000 of which are exercisable as of the date hereof.

F6: 25% of the shares underlying this stock option vested on December 9, 2020, the remainder of the shares underlying this stock option will continue to vest in equal monthly installments thereafter until December 9, 2023.